Reagent

Twist Bioscience Launches IVDR-compliant Precision Dx Products for Whole Exome Sequencing

Retrieved on: 
星期二, 三月 5, 2024

The suite of our CE-marked Products includes:

Key Points: 
  • The suite of our CE-marked Products includes:
    The Twist Precision Prep and Enrichment Dx Kit1 (Reagents for enzymatic fragmentation, library preparation, and target enrichment), which is panel-agnostic2
    Twist Precision Exome Dx Kit1 (Reagents for enzymatic fragmentation, library preparation, and target enrichment along with targeted capture probes for exome enrichment; IVDR compliant workflow)
    The Twist Precision Prep and Enrichment Dx Kit and the Twist Precision Exome Dx Panel can be used individually within existing workflows or as a combined solution known as the Twist Precision Exome Dx Kit.
  • “The Twist Precision Dx products are our first NGS product line specifically developed to be included within regulated customer products.
  • The Twist Precision Exome Dx Panel1 is a qualified Twist DNA panel that can be used in conjunction with the Twist Precision Prep and Enrichment Dx kit to produce exome-enriched libraries compatible for NGS applications.
  • Twist Precision Exome Dx Kit1 utilizes the qualified Twist Precision Exome Dx Panel along with the Twist Precision Prep and Enrichment Dx Kit to produce exome-enriched libraries compatible for NGS applications.

Site Survey Confirms Sodium Carbonate Potential at Laguna Santa Maria

Retrieved on: 
星期五, 三月 1, 2024

Soda ash is a critical reagent required to produce lithium carbonate; each tonne of lithium carbonate produced utilizes two tonnes of soda ash in processing.

Key Points: 
  • Soda ash is a critical reagent required to produce lithium carbonate; each tonne of lithium carbonate produced utilizes two tonnes of soda ash in processing.
  • Currently, much of the soda ash supply for the production of lithium carbonate in Argentina is sourced outside the country.
  • The 260 hectare Laguna Santa Maria appears as a salar or salt flat.
  • Work to date has included a Vertical Survey and a site visit with limited sampling.

Global Cardiac Marker Testing Market Expected to Reach $6.9 Billion by 2028, Driven by Aging Population and Rising Cardiovascular Diseases - ResearchAndMarkets.com

Retrieved on: 
星期四, 十一月 9, 2023

The global cardiac marker testing market is poised for substantial growth, with projections estimating it to reach USD 6.9 billion by 2028, a significant increase from its 2022 value of USD 4.1 billion.

Key Points: 
  • The global cardiac marker testing market is poised for substantial growth, with projections estimating it to reach USD 6.9 billion by 2028, a significant increase from its 2022 value of USD 4.1 billion.
  • Aging Population: The increasing global aging population has led to a higher prevalence of cardiovascular diseases.
  • Rising Cardiovascular Diseases: Cardiovascular diseases are on the rise worldwide, making cardiac marker testing an essential tool for the diagnosis and monitoring of these conditions.
  • In 2022, laboratory testing facilities represented the largest share, accounting for 61.2% of the global cardiac marker testing market.

Global Metagenomics Sequencing Research Report 2023:Government Funding Accelerates Innovations - Forecasts to 2028

Retrieved on: 
星期四, 十一月 9, 2023

The growth of the Global Metagenomics Sequencing Market has been significantly propelled by the continual advancements in sequencing technologies.

Key Points: 
  • The growth of the Global Metagenomics Sequencing Market has been significantly propelled by the continual advancements in sequencing technologies.
  • Notably, next-generation sequencing and single-molecule sequencing technologies have ushered in a transformative era by substantially augmenting the throughput, precision, and expediency of metagenomics sequencing.
  • Moreover, the advent of portable sequencing technologies has expanded the horizons of metagenomics sequencing by enabling on-site sequencing in field settings.
  • Further, expected to drive the growth of the Global Metagenomics Sequencing Market as farmers, researchers, and agribusinesses adopt metagenomics sequencing to optimize crop production and improve sustainability.

Global Metagenomics Sequencing Market Trends, Opportunities, Competition and Forecasts, 2018-2022 & 2023-2028 - ResearchAndMarkets.com

Retrieved on: 
星期三, 十一月 8, 2023

Personalized medicine is a key driver for the growth of the Global Metagenomics Sequencing Market.

Key Points: 
  • Personalized medicine is a key driver for the growth of the Global Metagenomics Sequencing Market.
  • The growth of the Global Metagenomics Sequencing Market has been significantly propelled by the continual advancements in sequencing technologies.
  • Notably, next-generation sequencing and single-molecule sequencing technologies have ushered in a transformative era by substantially augmenting the throughput, precision, and expediency of metagenomics sequencing.
  • Further, expected to drive the growth of the Global Metagenomics Sequencing Market as farmers, researchers, and agribusinesses adopt metagenomics sequencing to optimize crop production and improve sustainability.

Global Protein Labeling Market Size, Share & Trends Analysis Report 2023-2030 - Innovative Techniques Propel Global Protein Labeling Market Forward - ResearchAndMarkets.com

Retrieved on: 
星期五, 十月 27, 2023

Protein labeling is undergoing a significant transformation, driven by the burgeoning interest in Post-translational Modification (PTM) studies.

Key Points: 
  • Protein labeling is undergoing a significant transformation, driven by the burgeoning interest in Post-translational Modification (PTM) studies.
  • The application of advanced quantification methods, such as iodoTMTzero Label Reagent, is facilitating the efficient detection of PTMs, propelling the market forward.
  • Biomedical research is at the forefront of driving growth in the global protein labeling market.
  • The surge in PTM studies, fueled by breakthroughs in protein expression quantification and innovative tagging strategies, is a pivotal factor.

Microcarrier Market Poised to Reach $3.43 Billion by 2030: Driving Advances in Biopharmaceuticals and Vaccine Production - ResearchAndMarkets.com

Retrieved on: 
星期四, 十月 19, 2023

The global Microcarrier Market is poised to achieve a substantial valuation of US$ 3.43 billion by 2030, according to a comprehensive market analysis.

Key Points: 
  • The global Microcarrier Market is poised to achieve a substantial valuation of US$ 3.43 billion by 2030, according to a comprehensive market analysis.
  • The Microcarrier Market is experiencing significant growth, driven by the need to enhance vaccine production yields, reduce costs, and address a wide range of diseases.
  • These beads provide a flexible platform for cell attachment and growth, facilitating the production of biopharmaceuticals, vaccines, and cell-based therapies.
  • The United States stands out in the Microcarrier Market, known for its innovation and technological advancements.

Pharmaceutical and Biotechnology Companies Lead the Microcarrier Market with Innovation and R&D Investments

Retrieved on: 
星期一, 十月 16, 2023

The global Microcarrier Market is poised to achieve a substantial valuation of US$ 3.43 billion by 2030, according to a comprehensive market analysis.

Key Points: 
  • The global Microcarrier Market is poised to achieve a substantial valuation of US$ 3.43 billion by 2030, according to a comprehensive market analysis.
  • Pharmaceutical and biotechnology companies lead the Microcarrier Market, relying extensively on microcarriers for various applications.
  • Continuous investments in research and development, along with innovation in microcarrier technology, further bolster the demand for microcarriers.
  • The United States stands out in the Microcarrier Market, known for its innovation and technological advancements.

Globla Primary Cell Culture Industry's Vital Role in Advancing Precision Therapies and Regenerative Medicine Sparks Remarkable Growth - ResearchAndMarkets.com

Retrieved on: 
星期二, 九月 26, 2023

Primary cell culture, offering a closer emulation of human biology compared to traditional cell lines, has become indispensable for understanding disease mechanisms, advancing drug discovery, and facilitating therapeutic development.

Key Points: 
  • Primary cell culture, offering a closer emulation of human biology compared to traditional cell lines, has become indispensable for understanding disease mechanisms, advancing drug discovery, and facilitating therapeutic development.
  • Additionally, primary cell culture is playing a pivotal role in regenerative medicine, aiming to repair or replace damaged tissues and organs.
  • The growing interest and investment in regenerative medicine are propelling the growth of the primary cell culture market.
  • While the pandemic disrupted various sectors, it underscored the vital role of primary cell culture in comprehending viruses and developing treatments.

Advancements in Molecular Diagnostics Fuel Nucleic Acid Isolation Market with 8.5% CAGR Forecast Amid Rising Demand for High-Quality Nucleic Acids - ResearchAndMarkets.com

Retrieved on: 
星期一, 九月 18, 2023

The nucleic acid isolation and purification market is poised for significant growth with a projected Compound Annual Growth Rate (CAGR) of 8.5% during the forecast period from 2023 to 2031.

Key Points: 
  • The nucleic acid isolation and purification market is poised for significant growth with a projected Compound Annual Growth Rate (CAGR) of 8.5% during the forecast period from 2023 to 2031.
  • Molecular diagnostic tests for various diseases rely on efficient nucleic acid isolation and purification techniques.
  • Type of Nucleic Acid: Segmented into DNA Isolation & Purification and RNA Isolation & Purification, with RNA purification anticipated to grow rapidly.
  • Key Questions Answered in the Report:
    What factors are impacting the growth of the nucleic acid isolation and purification market?